Yang S K, Selkirk J K, Plotkin E V, Gelboin H V
Cancer Res. 1975 Dec;35(12):3642-50.
High-pressure liquid chromatography was used to analyze the rate of benzo(a)pyrene metabolite formation by liver microsomes from control and 3-methylcholanthrene-treated rats. The relative amounts of each metabolite formed were determined with several concentrations of microsomal mixed-function oxidases. The specific activity, i.e., amount formed per mg protein per min, was found to be constant for the formation of 3-hydroxybenzo(a)pyrene and 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene. The specific activity for the formation of 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene was higher at high microsomal enzyme concentration. The formation of 9-hydroxybenzo(a)pyrene, however, did not increase with greater amounts of microsomes. The data indicate that 9-hydroxybenzo(a)pyrene is a nonenzymatic product derived from a reactive intermediate, probably benzo(a)pyrene-9,10-oxide. The relatively constant specific activity for the formation of 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene with several enzyme concentrations suggests that the K-region epoxide, benzo(a)pyrene-4,5-oxide, is the most stable of the benzo(a)pyrene epoxide intermediates. The relative percentages of each metabolite fraction found are as follows: 3-hydroxybenzo(a)pyrene, 36; 9-hydroxybenzo(a)pyrene, 3 to 13; 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene, 15 to 25; 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene, 8; 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene, 12 to 14; benzo(a)pyrene quinones, 14 to 17. Induction of the enzyme system by 3-methylcholanthrene increases the amount of each metabolite formed to a different extent. The amount of 9,10-dihydro-9,10-dihydroxy- and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene formed are markedly increased relative to the increase in the other metabolites. Thus the induction of the enzyme may specifically alter pathways of metabolism relevant to carcinogenesis. This study also makes a detailed comparison between the results obtained by high-pressure liquid chromatography analysis and the standard aryl hydrocarbon hydroxylase assay and further develops the chromatographic analysis of benzo(a)pyrene metabolites.
采用高压液相色谱法分析对照组和经3-甲基胆蒽处理的大鼠肝脏微粒体形成苯并(a)芘代谢物的速率。用几种浓度的微粒体混合功能氧化酶测定每种代谢物形成的相对量。发现3-羟基苯并(a)芘和4,5-二氢-4,5-二羟基苯并(a)芘形成的比活性,即每分钟每毫克蛋白质形成的量是恒定的。在高微粒体酶浓度下,9,10-二氢-9,10-二羟基苯并(a)芘形成的比活性较高。然而,9-羟基苯并(a)芘的形成量不会随着微粒体数量的增加而增加。数据表明,9-羟基苯并(a)芘是一种由活性中间体(可能是苯并(a)芘-9,10-氧化物)衍生的非酶产物。在几种酶浓度下,4,5-二氢-4,5-二羟基苯并(a)芘形成的比活性相对恒定,这表明K-区域环氧化物苯并(a)芘-4,5-氧化物是苯并(a)芘环氧化物中间体中最稳定的。所发现的每种代谢物组分所占的相对百分比如下:3-羟基苯并(a)芘,36%;9-羟基苯并(a)芘,3%至13%;9,10-二氢-9,10-二羟基苯并(a)芘,15%至25%;4,5-二氢-4,5-二羟基苯并(a)芘,8%;7,8-二氢-7,8-二羟基苯并(a)芘,12%至14%;苯并(a)芘醌类,14%至17%。3-甲基胆蒽对酶系统的诱导使每种代谢物形成的量在不同程度上增加。相对于其他代谢物的增加,9,10-二氢-9,10-二羟基-和7,8-二氢-7,8-二羟基苯并(a)芘形成的量显著增加。因此,酶的诱导可能会特异性地改变与致癌作用相关的代谢途径。本研究还对高压液相色谱分析和标准芳烃羟化酶测定所获得的结果进行了详细比较,并进一步发展了苯并(a)芘代谢物的色谱分析方法。